PRI's Focus on Health Care

View this email in your browser ([link removed])

Doctors need a second opinion on ‘Medicare-for-all’

Fox News | Sally C. Pipes
January 27, 2020

These doctors may soon regret their decision. “Medicare-for-all” would saddle physicians with pay cuts, long hours, and rolls of regulatory red tape. That would cause even more doctors to burn out — and leave millions of Americans without access to quality care.

Read more . . . ([link removed])
[link removed]
Now an Amazon.com #1 bestseller among policy books (health law books).

Warren’s Medicare for All isn’t affordable for anyone

Featured in Real Clear Health and the Washington Times | Sally C. Pipes
January 22, 2020

Ms. Warren claims she can raise the $20.5 trillion needed for Medicare for All by raising taxes on the rich. She’s proposed increasing the corporate tax rate from 21 percent to 35 percent, generating $2.9 trillion over 10 years. The top 1 percent of households would pay new taxes on their capital gains, amounting to $2 trillion. Billionaires would also face a 6 percent wealth tax, which would supposedly deliver $1 trillion.
Read more. . . ([link removed])

Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs

Right By the Bay Blog | Kerry Jackson
January 27, 2020

Although the miracles of high-tech may capture the imagination and the headlines, there are many simpler and cheaper yet tremendously important innovations for the diagnosis and prevention of illness. Some are easy to monetize via conventional mechanisms, such as patents, periods of exclusivity enforced by regulators, or even good, old-fashioned advertising (as makers of walk-in bathtubs advertise directly to seniors).
Read more. . . ([link removed])

Price Controls Impose High Costs On Patients

Right By the Bay Blog | Kerry Jackson
January 23, 2020

Today, the U.S. defines the industry, with nearly 60% of all new drugs being developed in the United States. Germany, once one of the top global leaders, developed 6% of all new drugs. Switzerland, France, and the U.K. are not much more innovative, developing a mere 13%, 6%, and 8% of all new drugs, respectively.
Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.